Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice
Reheman Adili(St. Michael's Hospital), Michael Holinstat(University of Michigan), Xiangrong Dai(Lee's Pharmaceutical (China)), Benjamin Xiaoyi Li(Lee's Pharmaceutical (China)), Livia Stanger(University of Michigan), Madeline Jackson(University of Michigan), Mandy Li(Lee's Pharmaceutical (China))
Cited by 4
Related Papers
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies
|Thrombosis Journal|2016|196
Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis
|Nature Communications|2018|113
An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis
|Cell|2024|102
In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα
|Scientific Reports|2021|45
Protein Kinase C Regulation of 12-Lipoxygenase-Mediated Human Platelet Activation
|Molecular Pharmacology|2011|44